Navigation Links
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Date:12/23/2009

ors, LIVALO should be used with caution in patients who consume substantial quantities of alcohol. Active liver disease, which may include unexplained persistent transaminase elevations, is a contraindication to the use of LIVALO.

ADVERSE REACTIONS:

The following serious adverse reactions are discussed in greater detail in the full prescribing information:

  • rhabdomyolysis (a serious muscle disorder) with myoglobinuria (a laboratory test result), and acute renal (kidney) failure and myopathy including myositis (muscular pains), and
  • liver enzyme abnormalities (a laboratory test result).

In controlled clinical trials of up to 12 weeks duration adverse reactions were infrequent, the common adverse reactions, including their MedDRA and common names, reported by 2% or more of treated patients are: back pain, constipation or diarrhea, myalgia (muscular pain), and pain in the extremities (pain in arms or legs). Other adverse reactions reported from clinical studies were arthralgia (joint pain), headache, influenza (the flu), and nasopharyngitis (common cold). The following laboratory abnormalities have also been reported: elevated creatine phosphokinase, transaminases, alkaline phosphatase, bilirubin, and glucose.

In controlled clinical studies and their open-label extensions, 3.9% (1 mg), 3.3% (2 mg), and 3.7% (4 mg) of pitavastatin-treated patients were discontinued due to adverse reactions. The most common adverse reactions that led to treatment discontinuation were: elevated creatine phosphokinase (0.6% on 4 mg) and myalgia (0.5% on 4 mg).

DRUG INTERACTIONS:

As with other statin medications there is a chance of certain drug interactions while taking LIVALO. Caution is advised. The physician should consult the full prescribing information regarding suggested dose reductions or avoidance of LIVALO therapy when coadminstration of any of the following is being
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Ill. , Aug. 4, 2015 ... dental supplies and equipment, today announced the acquisition ... Medical Products Laboratories, Inc. ("MPL PDCMD"). MPL PDCMD ... used in preventive and restorative dental procedures. ... expansion of our business in attractive, high-growth segments," ...
(Date:8/4/2015)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ) announced ... executive vice president, research and development, will provide an ... development programs and an overview of the company,s ... 2015, at the 2015 Wedbush Pacgrow Healthcare Conference. The ... NY . The presentation will be ...
(Date:8/4/2015)... FRAMINGHAM, Mass. , Aug. 4, 2015 ... a leading innovator of less invasive, miniaturized circulatory support ... failure, today announced that its President and Chief Executive ... at the Canaccord Genuity 35th Annual Growth Conference at ... conference is being held August 12-13, 2015 at the ...
Breaking Medicine Technology:Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2
... NEW ORLEANS , May 3 ... developing novel catheter-mounted digital imaging devices, today announced five ... Retroscope® during colonoscopy procedures increases detection of adenomas and ... years of experience, were able to detect adenomas of ...
... Questcor Pharmaceuticals, Inc . (Nasdaq: QCOR ) today announced that it will ... Panel meeting on Monday, May 10, 2010 at ... Don Bailey , President and Chief Executive Officer; Steve Cartt ... Chief Science Officer; and Dr. Jason Zielonka , Senior Vice President and ...
Cached Medicine Technology:Third Eye(R) Retroscope(R) Demonstrates Improved Adenoma Detection 2Third Eye(R) Retroscope(R) Demonstrates Improved Adenoma Detection 3Third Eye(R) Retroscope(R) Demonstrates Improved Adenoma Detection 4Third Eye(R) Retroscope(R) Demonstrates Improved Adenoma Detection 5Third Eye(R) Retroscope(R) Demonstrates Improved Adenoma Detection 6Questcor to Discuss Results From FDA Panel Meeting 2
(Date:8/4/2015)... , ... August 04, 2015 , ... Statement by Paul ... the introduction of the Mental Health Reform Act of 2015 by Senators ... mental health reform a reality in America. , “This legislation and H.R. ...
(Date:8/4/2015)... ... August 04, 2015 , ... assistPoint Partners, LLC is ... oncology patient assistance programs. Through a secure web portal, assistPoint connects Life Sciences, ... enterprise level, cloud-based application and workflow solution. This provides cancer center patient advocates, ...
(Date:8/4/2015)... ... August 04, 2015 , ... Healthy ... Origins® Cognizin® is a trademark for Citicoline, a nutrient that supports memory function ... those applications which have more of a semi-solid composition. Vegetarian capsules are ...
(Date:8/4/2015)... ... August 04, 2015 , ... It’s hard ... Medical & Day Spa in Santa Barbara, CA is offering the solution by ... that permanently eliminates sweat and odor glands in the underarms. This simple and ...
(Date:8/4/2015)... ... August 04, 2015 , ... Recent studies ... a rise in binge drinking among certain populations and specific locations. ... continuing to examine trends and evidence to help facilitate health care treatment to ...
Breaking Medicine News(10 mins):Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:assistPoint.com Web Site Launched 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 3Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3
... University of the Rockies (UoR) has introduced a ... master,s or doctoral degree in Psychology."As the demand ... an increasing need for professionals to administer the ... provided," said Dr. Steve Kirkpatrick, Dean of the ...
... Letter to Governors Rendell, Douglas Says to Use Medicaid ... Feb. 23 In a new letter to National ... Douglas (R-VT), the Coalition to Protect Senior Care (CPSC), ... today urged the nation,s Governors to ensure new state ...
... 23 Nostrum Pharmaceuticals, LLC ("Nostrum"), a privately-held ... that it has obtained a worldwide license to ... derivatives and analogues ("Caerulomycin") for their novel indication ... Institute of Microbial Technology ("IMTECH"), Chandigarh, India, one ...
... teamed up with world famous "Hippocrates Health Institute" with ... of HHI are now able to take advantage of ... the source of what many doctors and alternative health ... health problems including obesity, skin problems, and even cancer, ...
... Star Sabrina Bryan Will Visit SchoolLEOTI, Kan., Feb. 23 ... the economy. One challenge was that the junior high gymnasium ... the students with no place to exercise indoors during the ... high managed to rally support for their dedication to health ...
... March 12, 2009 - 9:00 a.m. ET HOPKINTON, Mass., ... CALP ) will conduct a conference call discussing ... a.m. ET on Thursday, March 12. Kevin Hrusovsky, ... Financial Officer, will host the call. Management will discuss ...
Cached Medicine News:Health News:University of the Rockies Introduces Mental Health Administration Specialization for Psych Majors 2Health News:National Caregiver Coalition to National Governors Association: Establish State Task Forces to Monitor Medicaid Spending, Ascertain Funds Going to Protect Seniors 2Health News:National Caregiver Coalition to National Governors Association: Establish State Task Forces to Monitor Medicaid Spending, Ascertain Funds Going to Protect Seniors 3Health News:Nostrum Pharmaceuticals Obtains Worldwide Licensing Rights From IMTECH for Clinical Development of the Small Molecule Caerulomycin and Its Proprietary Derivatives for Their Novel Indication of Immunosuppression 2Health News:Nostrum Pharmaceuticals Obtains Worldwide Licensing Rights From IMTECH for Clinical Development of the Small Molecule Caerulomycin and Its Proprietary Derivatives for Their Novel Indication of Immunosuppression 3Health News:LuxSauna Teams With World Famous Detox Health Retreat 'Hippocrates Health Institute' 2Health News:Leoti, Kan. Junior High Finds Ways to Exercise, Wins National Health Contest 2Health News:Leoti, Kan. Junior High Finds Ways to Exercise, Wins National Health Contest 3Health News:Leoti, Kan. Junior High Finds Ways to Exercise, Wins National Health Contest 4Health News:Caliper Life Sciences' Fourth Quarter 2008 Financial Results Conference Call Notice 2
... Web-based and RFID-enabled location system that allows ... flow and utilization of resources throughout the ... collects patient information including location, and alerts ... experience. This information is directed to both ...
... Radianse indoor positioning solution ... of where and when ... flow through care processes. ... provides intelligence that hospitals ...
... enables healthcare facilities to provide a higher ... throughput utilizing one low cost infrastructure and ... Mobile Aspects active RFID tags, small enough ... and can house pertinent patient information such ...
VACUETTE PaediatricMulti-Sample Needle...
Medicine Products: